Article Text

Download PDFPDF
Trading death and disability in malignant stroke
  1. David S Liebeskind
  1. Dr David S Liebeskind, UCLA Stroke Center, 710 Westwood Plaza, Los Angeles, CA 90095, USA; davidliebeskind{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Investigating introspective aspects of informed consent in a contemporary stroke trial

The process of informed consent is considerably complex in acute stroke. In this issue of J Neurol Neurosurg Psychiatry, Hofmeijer and colleagues1 examined informed consent for hemicraniectomy in malignant stroke, a particularly difficult clinical scenario that underscores the uncertainty, limited evidence and complexity that clinicians must convey to patients and families regarding stroke, and seemingly heroic measures that have recently allowed for positive outcomes in select cases (see page 1124). Hemicraniectomy or decompressive surgery for malignant stroke superimposes further complexity. Such a surgical option is entertained only when the perceived …

View Full Text


  • Competing interests: None.

Linked Articles